ZIBOR 25.000 i.e. anti-Xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zibor 25.000 i.e. anti-xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah

frosst iberica s.a. - natrijev bemiparinat - raztopina za injiciranje v napolnjeni injekcijski brizgi - natrijev bemiparinat 10000 i.e. / 0,3 ml - bemiparin

ZIBOR 25.000 i.e. anti-Xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zibor 25.000 i.e. anti-xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah

frosst iberica s.a. - natrijev bemiparinat - raztopina za injiciranje v napolnjeni injekcijski brizgi - natrijev bemiparinat 10000 i.e. / 0,2 ml - bemiparin

ZIBOR 25.000 i.e. anti-Xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zibor 25.000 i.e. anti-xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah

frosst iberica s.a. - natrijev bemiparinat - raztopina za injiciranje v napolnjeni injekcijski brizgi - natrijev bemiparinat 10000 i.e. / 0,4 ml - bemiparin

Spikevax (previously COVID-19 Vaccine Moderna) Evropska unija - slovenščina - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Okedi Evropska unija - slovenščina - EMA (European Medicines Agency)

okedi

laboratorios farmacéuticos rovi, s.a. - risperidone - shizofrenija - psiholeptiki - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.